# Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.

> **NCT01382550** · — · UNKNOWN · sponsor: **Federico II University** · enrollment: 900 (estimated)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** long-lasting OAT or 12-month OAT

## Key facts

- **NCT ID:** NCT01382550
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 1993-03
- **Primary completion:** 2012-09
- **Final completion:** —
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2012-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382550, "Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01382550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*